Recall events
/
Event 84213
Event summary
Timeline bucket November 08, 2019
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Washington Homeopathic Products, Inc.
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
16 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 16
Calcarea Fluorica 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64188 0.
D-0491-2020
Recall number D-0491-2020
Initiated November 08, 2019
Classification Class II
Status Terminated
Quantity 489 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations: products were not manufactured under current good manufacturing practices.
Code information Lot #: BR18C279
Distribution pattern Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11808]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 16
Calcarea Phosphorica 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64189 7.
D-0492-2020
Recall number D-0492-2020
Initiated November 08, 2019
Classification Class II
Status Terminated
Quantity 681 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations: products were not manufactured under current good manufacturing practices.
Code information Lot #: BR18C282 and BR18K166
Distribution pattern Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11941]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 16
Calcarea Sulphurica 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64190 3.
D-0493-2020
Recall number D-0493-2020
Initiated November 08, 2019
Classification Class II
Status Terminated
Quantity 300 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations: products were not manufactured under current good manufacturing practices.
Code information Lot #: BR18B277
Distribution pattern Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11907]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 16
Cell Salts Combination 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64200 9.
D-0494-2020
Recall number D-0494-2020
Initiated November 08, 2019
Classification Class II
Status Terminated
Quantity 829 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations: products were not manufactured under current good manufacturing practices.
Code information Lot #: BC18C142 and BC18G056
Distribution pattern Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11875]
FDA event record
· Exact recall-number query on openFDA
drug · product 5 of 16
Ferrum Phosphoricum 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64198 9.
D-0495-2020
Recall number D-0495-2020
Initiated November 08, 2019
Classification Class II
Status Terminated
Quantity 462 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations: products were not manufactured under current good manufacturing practices.
Code information Lot # BR18C281
Distribution pattern Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11556]
FDA event record
· Exact recall-number query on openFDA
drug · product 6 of 16
Kali Muriaticum 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64194 1.
D-0496-2020
Recall number D-0496-2020
Initiated November 08, 2019
Classification Class II
Status Terminated
Quantity 300 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations: products were not manufactured under current good manufacturing practices.
Code information Lot #: BR18B275
Distribution pattern Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11916]
FDA event record
· Exact recall-number query on openFDA
drug · product 7 of 16
Kali Phosphoricum 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64195 8.
D-0497-2020
Recall number D-0497-2020
Initiated November 08, 2019
Classification Class II
Status Terminated
Quantity 417 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations: products were not manufactured under current good manufacturing practices.
Code information Lot #: BR18B272
Distribution pattern Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11816]
FDA event record
· Exact recall-number query on openFDA
drug · product 8 of 16
Kali Sulphuricum 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64196 5.
D-0498-2020
Recall number D-0498-2020
Initiated November 08, 2019
Classification Class II
Status Terminated
Quantity 295 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations: products were not manufactured under current good manufacturing practices.
Code information Lot #: BR18B276
Distribution pattern Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11566]
FDA event record
· Exact recall-number query on openFDA
drug · product 9 of 16
Magnesia Phosphorica 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64197 2.
D-0499-2020
Recall number D-0499-2020
Initiated November 08, 2019
Classification Class II
Status Terminated
Quantity 487 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations: products were not manufactured under current good manufacturing practices.
Code information Lot #: BR18C283
Distribution pattern Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11776]
FDA event record
· Exact recall-number query on openFDA
drug · product 10 of 16
Natrum Muriaticum 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64191 0.
D-0500-2020
Recall number D-0500-2020
Initiated November 08, 2019
Classification Class II
Status Terminated
Quantity 366 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations: products were not manufactured under current good manufacturing practices.
Code information Lot #: BR18B274
Distribution pattern Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11770]
FDA event record
· Exact recall-number query on openFDA
drug · product 11 of 16
Natrum Phosphoricum 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64192 7.
D-0501-2020
Recall number D-0501-2020
Initiated November 08, 2019
Classification Class II
Status Terminated
Quantity 366 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations: products were not manufactured under current good manufacturing practices.
Code information Lot #: BR18B273
Distribution pattern Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11946]
FDA event record
· Exact recall-number query on openFDA
drug · product 12 of 16
Natrum Sulphuricum 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64193 4.
D-0502-2020
Recall number D-0502-2020
Initiated November 08, 2019
Classification Class II
Status Terminated
Quantity 288 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations: products were not manufactured under current good manufacturing practices.
Code information Lot #: BR18C280
Distribution pattern Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11768]
FDA event record
· Exact recall-number query on openFDA
drug · product 13 of 16
Silicea 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64199 6.
D-0503-2020
Recall number D-0503-2020
Initiated November 08, 2019
Classification Class II
Status Terminated
Quantity 426 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations: products were not manufactured under current good manufacturing practices.
Code information Lot #: BR18B278
Distribution pattern Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11262]
FDA event record
· Exact recall-number query on openFDA
drug · product 14 of 16
Pareira (Brava) 1X Tincture, 50 mL bottle, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.
D-0504-2020
Recall number D-0504-2020
Initiated November 08, 2019
Classification Class II
Status Terminated
Quantity 1 bottle
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations: products were not manufactured under current good manufacturing practices.
Code information Lot #: 101471, Exp 08/01/2020
Distribution pattern Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11882]
FDA event record
· Exact recall-number query on openFDA
drug · product 15 of 16
StellaLife VEGA Oral Gel Rinse (In equal parts of: Azadirachta Indica 1x, Calendula Officinalis 1x, Echinacea Purpurea 1x, Plantago Major 1x), packaged in 1000 mL white plastic bottle.
D-0505-2020
Recall number D-0505-2020
Initiated November 08, 2019
Classification Class II
Status Terminated
Quantity 1 bottle/
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations: products were not manufactured under current good manufacturing practices.
Code information Lot # 29488
Distribution pattern Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11297]
FDA event record
· Exact recall-number query on openFDA
drug · product 16 of 16
R2103, Active Ingredients: Berberis Aquifolium 3x; Borax 3; , Kreosotum 10X; Sepia 3x. Inactive ingredient: 28% dilution alcohol, packaged in a) 470 mL bottle and b) 1000 mL bottle; Manufactured for Wisconsin Pharmacal Company, By: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411.
D-0506-2020
Recall number D-0506-2020
Initiated November 08, 2019
Classification Class II
Status Terminated
Quantity a) 1 bottle; b) 11 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations: products were not manufactured under current good manufacturing practices.
Code information Lot #: 28557
Distribution pattern Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11820]
FDA event record
· Exact recall-number query on openFDA
